Amwill Health Care IPO

Founded in August 2017, Amwill Health Care Limited is a derma-cosmetic development company that partners with contract manufacturers, distributors, and third-party product development agencies, enhancing its capabilities in manufacturing, packaging, and distribution. The company’s product range focuses on two categories: generic dermatological solutions and targeted treatments for skin conditions. Amwill operates primarily in Karnataka, Andhra Pradesh, and Telangana, aiming to establish a strong presence before expanding. Their products address acne, fungal infections, anti-ageing, pigmentation, scabies, perspiration, trichology, and vitiligo. As of April 30, 2024, the company employs 59 people, including 31 in marketing.

IPO Strengths

• Diverse product portfolio supported by strong product formulation capabilities

• High-quality product development through partnerships with contract manufacturers and prototype developers

• Asset-light business model, ensuring greater flexibility and operational efficiency

• Experienced management team with proven project management and implementation expertise

Amwill Healthcare IPO Key Financials (in ₹ lakhs)

Amwill Healthcare Limited Upcoming IPO Details

Amwill Healthcare IPO Important Dates

Amwill Healthcare IPO Lots

Amwill Healthcare IPO Lead Managers

Amwill Healthcare Limited IPO Valuation Overview

Amwill Healthcare IPO Peer Group Comparison

Objectives of the Proceeds

• Funding of working capital requirements, ₹2500 lakhs

• Towards marketing and brand building activities, ₹500 lakhs

• Meeting general corporate expenses